← Back to headlines
Silence Therapeutics Reports GAAP EPS of -$0.09, Beating Estimates
Silence Therapeutics announced its GAAP EPS of -$0.09, which surpassed analyst expectations by $0.08.
10 Aug, 11:17 — 10 Aug, 11:17
Sources
Showing 1 of 1 sources
Silence Therapeutics announced its GAAP EPS of -$0.09, which surpassed analyst expectations by $0.08.
